Timothy G. Youngquist 2020 Irrevocable Trust’s Day One Biopharmaceuticals DAWN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-53,399
Closed -$1.14M 218
2026
Q1
$1.14M Buy
+53,399
New +$752K 0.49% 59

Other funds holding DAWN

Timothy G. Youngquist 2020 Irrevocable Trust's DAWN Position: Q2 2026 in Review

Timothy G. Youngquist 2020 Irrevocable Trust sold out of Day One Biopharmaceuticals (DAWN) in Q2 2026, closing a stake of 53,399 shares — an estimated $1.14M sold.

Timothy G. Youngquist 2020 Irrevocable Trust first reported a position in DAWN in Q1 2026 and held it in 1 quarter. The position peaked at $1.14M in Q1 2026. 1 fund tracked by Wall St. Rank holds DAWN as of Q2 2026.

  • Timothy G. Youngquist 2020 Irrevocable Trust reported no remaining Day One Biopharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Timothy G. Youngquist 2020 Irrevocable Trust sold 53,399 Day One Biopharmaceuticals shares in Q2 2026, an estimated $1.14M.
  • Timothy G. Youngquist 2020 Irrevocable Trust first reported a position in Day One Biopharmaceuticals in Q1 2026 and held it in 1 quarter.
  • Timothy G. Youngquist 2020 Irrevocable Trust's Day One Biopharmaceuticals position peaked at $1.14M in Q1 2026.
  • 1 fund tracked by Wall St. Rank held Day One Biopharmaceuticals as of Q2 2026.

Based on Timothy G. Youngquist 2020 Irrevocable Trust's 13F filing for Q2 2026, filed 7 Aug 2026.